Kaposi sarkomu (KS) 1872 yılında, Moritz Kaposi tarafından, “derinin idyopatik, multipl, pigmente hemorajik sarkomu” adıyla tanımlanmıştır. Önceleri sıklıkla Doğu Avrupa, Akdeniz ve Yahudi kökenli yaşlı erkeklerin bir hastalığı olarak tanınan Kaposi sarkomu, 1980’li yıllarda homoseksüel erkeklerde akkiz immun yetmezlik sendromu’nun (AIDS) gündeme gelmesi ile birlikte yaygınlaşmıştır. Benzer histopatolojik görünüm ve immunhistokimyasal bulgular taşıyan, klasik, Afrika’da görülen endemik, iyatrojenik immun yetmezlik ile birlikte görülen ve AIDS le ilişkili Kaposi sarkomu tipleri mevcuttur. Radyasyona oldukça duyarlı olduğu bilinen Kaposi sarkomlarında ağrı, kanama ve ödem bulgularının lokal ve palyatif tedavisi için radyoterapi uygulanmaktadır. Bu yazıda, ağrılı ve kanamalı lezyonların palyatif tedavisi için lokal radyoterapi uygulanan ve tedaviye iyi yanıt veren klasik Kaposi sarkomlu 86 yaşındaki erkek olgu sunulmuş ve lokal radyoterapinin etkinliği literatür verileri eşliğinde gözden geçirilmiştir
Kaposi's sarcoma (KS) was described in 1872 by Moritz Kaposi as multiple benign pigmented idiopathic hemorrhagic sarcoma. KS, which was previously known as the disease of the older males of Eastern European, Mediterranean, or Jewish descent, became well-known with the increase of affected patients with acquired immunodeficiency syndrome (AIDS)in 1980s. Subtypes of KS, including the ones which represent histopathologic and immunohistochemical features and which are classical, endemic widespread in Africa, are available. Also, the other type is related to AIDS and immunosuppressive treatment. Radiation therapy often represents the optimal local therapy for paliation of pain, bleeding or edema in this radioresponsive tumor type. In this report, a 86-year-old male patient with the diagnosis of classical KS who was treated with radiotherapy is presented. The efficiency of radiation therapy for KS is evaluated based on the literature data.
1. Murphy WG, Davies MJ, Eduardo A: Haemostatic response to surgery and trauma. Br J Anaesth 1993;70:205-13.
2. Brummel-Ziedins K, Orfeo T, Jenny NS, Everse SJ, Mann KG: Blood coagulation and fibrinolysis. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds. Wintrobe’s Clinical Hematology. 11th ed. Philadelphia, Lea & Febiger, pp: 677–774, 2004.
3. Mann KG: Normal hemostasis. In: Kelley WN, ed. Textbook of Internal Medicine. 3rd ed. Philadelphia, Lippincott Williams & Wilkins, pp: 1240-5, 1997.
4. Kelly DA, Tuddenham EL: Hemostatic problems in liver disease. Gut 1986;27:339-49.
5. Remuzzi G: Bleeding in renal failure. Lancet 1988;1:1205-8.
6. Nichols WK: Disseminated intravascular coagulation. Semin Vasc Surg 1988;1:190-6.
7. Greaves M, Preston FE: Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, Cloves AV, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 4th ed. Philadelphia, Lippincott Williams & Wilkins, pp: 783-94, 2000.
8. Rodgers GM: Diagnostic approach to the bleeding disorders. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds. Wintrobe’s Clinical Hematology. 11th ed. Philadelphia, Lea & Febiger, pp: 1511–28, 2004.
9. Bradbury AW, Bachoo P, Milne AA, Duncan JL: Platelet count and the outcome of ruptured abdominal aortic aneurysm. J Vasc Surg 1995;21:484-91.
10. Aghajanian A, Grimes DA: Routine prothrombin time determination before elective gynecologic operations. Obstet Gynecol 1991;78:837-9.
11. Messmore HL, Goodwin J: Medical assessment of bleeding in the surgical patient. Med Clin North Am 1994;78:625-34.
12. Suchman AL, Griner PF: Diagnostic uses of the activated partial thromboplastin time and prothrombin time. Ann Intern Med 1986;104: 810-6.
13. Weaver DW: Differential diagnosis and management of unexplained bleeding. Surg Clin North Am 1993;73:353-61.
14. Abildgaard CF: Diagnosis of von Willebrand’s disease. In: Kaspar C, ed. Recent Advances in Hemophila Care. New York, Alan R. Liss, pp: 263, 1990.
15. Rapaport S: Preoperative hemostatic evaluation: which tests if any? Blood 1983;61:229-31.
16. Fellin F, Murphy S: Hematologic problems in the preoperative patient. Med Clin North Am 1987;71:477-87.
17. Kitchens CS: Surgery in hemophilias and related disorders. Medicine (Baltimore) 1986;65:34-7.
18. Blomback M, Johannson G, Johnson H, Swedenborg J, Wabo E: Surgery in patients with von Willebrand’s disease. Br J Surg 1989;76:398-400.
19. Manucci PM: Desmopressin, a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988;72:1449-55.
20. Messmer KF: Acceptable hematocrit level in surgical patients. World J Surg 1987;11:41-6.
21. Gold MS, Dietz PA, Heneghan SJ, MacMillan RW, Moglia RM, Rudnicki M: Emergency surgery in hematologic patients. World J Surg 1996;20:1133–40.
22. Bick RL, Pegram M: Syndromes of hypercoagulability and thrombosis: a review. Semin Thromb Hemost 1994;29:109-32.
23. Serafani AN, Spoliansky G, Sfakiawakis GN, Montaluo B, Jensen WN: Diagnostic studies in patients with sickle cell anemia and acute abdominal pain. Arch Intern Med 1987;147:1061-2.
24. Büyükaşık Y, Koşar A, Demiroğlu H, Altınok G, Özcebe Öİ, Dündar S: Acalculous acute cholecystitis in leukemia. J Clin Gastroenterol 1998;27:146–8.
25. Kim KU, Kim JK, Won JH, Hong DS, Park HS: Acute appendicitis in patients with acute leukemia. Korean J Intern Med. 1993;8:40–5.
26. D’Souza S, Lindberg M: Typhlitis as a presenting manifestation of acute myelogenous leukaemia. South Med J 2000;93:218–20.
27. Hohenberger P, Buchheidt D: Surgical interventions in patients with hematologic malignancies. Critical Reviews in Oncology / Hematology 2005;55:83–91.
28. Sadoff J, Hwang S, Rosenfeld D, Ettinger L, Spigland N: Surgical pancreatic complications induced by lasparaginase. J Pediatr Surg 1997;32:860–3.
29. Rescorla FJ, Grosfeld JL: Cholecystitis and cholelithiasis in children. Semin Pediatr Surg 1992;1:98-106.
30. Schubert TT: Hepatobiliary system in sickle cell disease. Gastroenterology 1986;90:2013-21.
31. Anderson PE: Neutropenic enterocolitis treated by primary resection with anastomosis in a leukaemic patient receiving chemotherapy. Aust N Z J Surg 1993;63:74–6.
32. Larsen TK, Qvist N, Bak M: Delayed neutropenic enterocolitis in a 12-year-old girl treated with total colectomy and J-pouch reservoir. J Pediatr Surg 2001;36:1066–7.
33. Quigley MM, Bethel K, Nowacki M, Millard F, Sharpe R: Neutropenic enterocolitis: a rare presenting complication of acute leukemia. Am J Hematol 2001;66:213–9.
34. Song HK, Kreisel D, Canter R, Krupnick AS, Stadtmauer EA, Buzby G: Changing presentation and management of neutropenic enterocolitis. Arch Surg 1998;133:979–82.
35. Maschmeyer G, Bertschat FL, Moesta KT: Outcome analysis of 189 consecutive cancer patients referred to the Intensive Care Unit in an emergency during a twoyear period. Eur J Cancer 2003;39:783–92.
36. Cohen JS, Paz IB, O’Donnell MR, Ellenhorn JD: Treatment of perianal infection following bone marrow transplantation. Dis Colon Rectum 1996;39:981–5.
37. Büyükaşık Y, Özcebe Oİ, Sayınalp N, Haznedaroğlu İC, Altundağ ÖÖ, Özdemir O, Dündar S: Perianal infections in patients with leukemia: importance of the course of neutrophil count. Dis Colon Rectum 1998;41:81–5.